Kamataki Tetsuya | Lab. Drug Metab. Hokkaido Univ.
スポンサーリンク
概要
関連著者
-
Kunitou Hideo
Natl. Cancer Center
-
KAMATAKI Tetsuya
Lab. Drug Metab., Grad. Sch. Pharm. Sci., Hokkaido Univ.
-
Kamataki Tetsuya
Lab. Drug Metab. Grad. Sch. Pharm. Sci. Hokkaido Univ
-
SAWAMURA Yuichi
Maruyama Clinic
-
Kamataki Tetsuya
Lab. Drug Metab. Hokkaido Univ.
-
Nemoto Nobuo
Fac. Pharm. Sci. Toyama Med. Pharm. Univ.
-
ARIYOSHI Noritaka
Lab. Drug Metab., Hokkaido Univ.
-
MIYAMOTO Masami
Lab. Drug Metab., Hokkaido Univ.
-
UMETSU Yuri
Lab. Drug Metab., Hokkaido Univ.
-
YOKOTA Jun
Natl. Cancer Center
-
Umetsu Yuri
Lab. Drug Metab. Hokkaido Univ.
-
Miyamoto Masami
Lab. Drug Metab. Hokkaido Univ.
-
Ariyoshi Noritaka
Lab. Drug Metab. Hokkaido Univ.
-
Kamataki Tetsuya
Lab. Drug Metab. Fac. Pharm. Sci. Hokkaido University
-
Sato Kunio
Dept. Internal Med. Gunma Univ. Sch. Med.
-
Dosaka-akita Hirotoshi
Dept. Internal Med. Hokkaido Univ. Med. Sch.
-
KUNITOH Hideo
Natl. Cancer Center
-
SAWAMURA Yu-ichi
Maruyama Clinic
-
AKITA Hirotoshi
1st Dept. Medicine, Hokkaido Univ. Sch. Med.
-
YOKOTA Jun
National Cancer Center Res. Inst.
-
KUNITOU Hideo
National Cancer Center Hospital
-
NEMOTO Nobuo
Sch. Pharm. Sci., Toyama Med. and Pharm. Univ.
-
Akita Hirotoshi
1st Dept. Medicine Hokkaido Univ. Sch. Med.
著作論文
- W1-2 Toxicological Significance of Genetic Polymorphism of Cytochrome P450 : Genetic Polymorphism of CYP2A6 and Lung Cancer Risk.(Proceedings of the 27th Annual Meeting)
- 21C-01-2 Relationship Between Genetic Polymorphism of CYP2A6 and Lung Cancer Risk.